Home › Trial NCT00664677
Phase 1 Study of Terameprocol (EM-1421) in Patients With Leukemia
- Trial IDNCT00664677
- StatusTerminated
- PhasePhase 1
- Study typeInterventional
- SponsorErimos Pharmaceuticals
- Enrollment16
- Start date2007-08
- ConditionsLeukemias · Acute Myeloid Leukemia (AML) · Acute Lymphocytic Leukemia (ALL) · Adult T Cell Leukemia (ATL) · Chronic Myeloid Leukemia (CML-BP) · Chronic Lymphocytic Leukemia (CLL)
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.